{"id":"https://openalex.org/W2011783391","doi":"https://doi.org/10.1097/00008571-199810000-00006","title":"Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype","display_name":"Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype","publication_year":1998,"publication_date":"1998-10-01","ids":{"openalex":"https://openalex.org/W2011783391","doi":"https://doi.org/10.1097/00008571-199810000-00006","mag":"2011783391","pmid":"https://pubmed.ncbi.nlm.nih.gov/9825833"},"language":"en","primary_location":{"id":"doi:10.1097/00008571-199810000-00006","doi":"https://doi.org/10.1097/00008571-199810000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199810000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020332680","display_name":"Helen Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H Powell","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, The University of Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, The University of Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111755367","display_name":"N.R. Kitteringham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N R Kitteringham","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006847944","display_name":"Munir Pirmohamed","orcid":"https://orcid.org/0000-0002-7534-7266","observed_orcids":["https://orcid.org/0000-0002-7534-7266"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Pirmohamed","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110016775","display_name":"Don Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D A Smith","raw_affiliation_strings":["Department of Drug Metabolism, Pfizer Central Research, Sandwich, Kent UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Pfizer Central Research, Sandwich, Kent UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029022001","display_name":"B K Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B K Park","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, The University of Liverpool. Liverpool UK","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.7688,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.9597973,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"8","issue":"5","first_page":"411","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyp2e1","display_name":"CYP2E1","score":0.9559999704360962},{"id":"https://openalex.org/keywords/human-liver","display_name":"human liver","score":0.8930000066757202},{"id":"https://openalex.org/keywords/mrna-expression","display_name":"mRNA expression","score":0.6579999923706055},{"id":"https://openalex.org/keywords/enzyme-activity","display_name":"enzyme activity","score":0.5740000009536743},{"id":"https://openalex.org/keywords/rsai-polymorphism","display_name":"RsaI polymorphism","score":0.8799999952316284},{"id":"https://openalex.org/keywords/5-flanking-region","display_name":"5'-flanking region","score":0.9350000023841858},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.7559999823570251},{"id":"https://openalex.org/keywords/chlorzoxazone","display_name":"chlorzoxazone","score":0.7760000228881836},{"id":"https://openalex.org/keywords/4-nitrophenol","display_name":"p-nitrophenol","score":0.996999979019165},{"id":"https://openalex.org/keywords/xenobiotic-metabolism","display_name":"xenobiotic metabolism","score":0.8240000009536743},{"id":"https://openalex.org/keywords/metabolic-activation","display_name":"metabolic activation","score":0.6110000014305115},{"id":"https://openalex.org/keywords/enzyme-regulation","display_name":"enzyme regulation","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C2776658834","wikidata":"https://www.wikidata.org/wiki/Q3294630","display_name":"Chlorzoxazone","level":5,"score":0.9280080795288086},{"id":"https://openalex.org/C140027455","wikidata":"https://www.wikidata.org/wiki/Q14864434","display_name":"CYP2E1","level":4,"score":0.7929493188858032},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7207090854644775},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.6426874399185181},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5877790451049805},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.534386396408081},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.5317949652671814},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.5069808959960938},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4894477427005768},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.48231005668640137},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4541952908039093},{"id":"https://openalex.org/C168007829","wikidata":"https://www.wikidata.org/wiki/Q857299","display_name":"Restriction fragment length polymorphism","level":4,"score":0.45368847250938416},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2730262279510498},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2392684519290924}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002753","descriptor_name":"Chlorzoxazone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006900","descriptor_name":"Hydroxylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009596","descriptor_name":"Nitrophenols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012150","descriptor_name":"Polymorphism, Restriction Fragment Length","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014019","descriptor_name":"Tissue Donors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019392","descriptor_name":"Cytochrome P-450 CYP2E1","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D019392","descriptor_name":"Cytochrome P-450 CYP2E1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019392","descriptor_name":"Cytochrome P-450 CYP2E1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00008571-199810000-00006","doi":"https://doi.org/10.1097/00008571-199810000-00006","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008571-199810000-00006","pdf_url":null,"source":{"id":"https://openalex.org/S196130971","display_name":"Pharmacogenetics","issn_l":"0960-314X","issn":["0960-314X","1473-561X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"journal-article"},{"id":"pmid:9825833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9825833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacogenetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2419391152","https://openalex.org/W4242641888","https://openalex.org/W1961883110","https://openalex.org/W304285802","https://openalex.org/W2048806256","https://openalex.org/W2371720476","https://openalex.org/W2966469224","https://openalex.org/W1983710263","https://openalex.org/W1479936619","https://openalex.org/W2065578523"],"abstract_inverted_index":{"Cytochrome":[0],"P4502E1":[1],"(CYP2E1)":[2],"is":[3,10,31,191,210],"constitutively":[4],"expressed":[5],"in":[6,45,63,73,91,96,106,158,171,194,216],"human":[7,75,196],"liver":[8,76],"and":[9,27,39,42,48,70,78,110,120,124,134,140,152,186,207],"responsible":[11],"for":[12,138,166],"the":[13,64,85,92,103,156,168,187,195,204],"metabolic":[14],"bioactivation":[15],"of":[16,20,25,55,66,149,184,200,224,229],"a":[17,23,74,128,181,201],"wide":[18],"variety":[19],"xenobiotics,":[21],"including":[22,36],"number":[24],"protoxins":[26],"procarcinogens.":[28],"CYP2E1":[29,67,97,107,159,185,208],"expression":[30],"regulated":[32],"at":[33],"several":[34],"levels":[35,65],"pre-transcriptional,":[37],"transcriptional":[38],"post-transcriptional":[40],"levels,":[41],"any":[43,148],"variation":[44,104,157],"enzyme":[46],"concentration":[47],"hence":[49],"activity":[50,72,112,126,160,209],"may":[51],"represent":[52],"increased":[53],"risk":[54],"toxicity":[56],"or":[57],"carcinogenicity.":[58],"We":[59],"have":[60],"investigated":[61],"variability":[62],"mRNA,":[68],"protein":[69,108,123],"functional":[71,111,125],"bank,":[77],"attempted":[79],"to":[80,84],"relate":[81],"these":[82,150],"parameters":[83,151],"RsaI":[86,169,205],"restriction":[87],"fragment":[88],"length":[89],"polymorphism":[90,170,206,226],"5'-flanking":[93],"region.":[94],"Variation":[95],"mRNA":[98,153],"(18-fold)":[99],"was":[100,144],"greater":[101],"than":[102],"seen":[105],"(twofold)":[109],"(fourfold)":[113],"determined":[114],"using":[115],"two":[116],"probe":[117],"substrates,":[118],"chlorzoxazone":[119,139],"p-nitrophenol.":[121],"Although":[122],"showed":[127],"significant":[129],"correlation":[130,146],"(r":[131],"=":[132,136],"0.93":[133],"r":[135],"0.83":[137],"p-nitrophenol,":[141],"respectively),":[142],"there":[143],"no":[145],"between":[147,203],"levels.":[154],"Also,":[155],"could":[161],"not":[162,220],"be":[163],"directly":[164],"accounted":[165],"by":[167],"our":[172,176],"samples.":[173],"In":[174],"conclusion,":[175],"results":[177],"are":[178],"consistent":[179,211],"with":[180,212],"complex":[182],"regulation":[183],"fact":[188],"that":[189],"it":[190],"highly":[192],"conserved":[193],"population.":[197],"The":[198],"absence":[199],"relationship":[202],"other":[213],"studies":[214],"performed":[215],"Caucasians,":[217],"but":[218],"does":[219],"exclude":[221],"an":[222],"effect":[223],"this":[225],"on":[227],"inducibility":[228],"CYP2E1.":[230]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}